Data as of Sep 25, 2026 · Based on 4,025,084 AI responses across 13,338 prompts · See how Parse measures this
Parexelparexel.comParexel provides end-to-end clinical development, regulatory, and market access solutions, spanning portfolio optimization, asset valuation, early development, integrated development, approvals, and lifecycle management. It delivers Phase I–IV clinical trials, real-world evidence, pharmacovigilance, regulatory submissions, and market access strategy and delivery to maximize global reach and product value. Through ParexelAI, an AI-enabled clinical development suite, and broad therapeutic expertise, Parexel accelerates delivery and improves speed, quality, and efficiency in drug development.
The market map · 5 of 100 labelled
Clinical Trial Management Software →AI rates
IQVIAAI rates Parexel worse than a rival on startup suitability in 3 answers, and never better. IQVIA is named most.Worse than rivalsBetter than rivals
Veeva Vault CTMSPicked instead3 questions
Excerpts where Parexel appeared in the AI's answer
Parexel — Widely recognized for full-service clinical development from Phase I to IV, with specialized precision oncology frameworks scaling into Europe.
Parexel — a strong option for global oncology programs requiring substantial regulatory, operational and patient-recruitment infrastructure.
Excerpts where Parexel appeared in the AI's answer
Parexel — Worth including where regulatory strategy, specialized therapeutic expertise, and flexible outsourcing are important.
Parexel (Dedicated Biotech Offering) - The Vibe: Enterprise-grade capabilities scaled down for small teams.
Excerpts where Parexel appeared in the AI's answer
Parexel / Signant Health / Veeva — Enterprise-grade clinical technology providers that offer modular eConsent and patient-facing apps, frequently paired with strategic partnerships for decentralized mobile health nursing orchestration.
MedablePicked instead2 questions
OmnisciencePicked instead1 question
Medidata Rave CTMSPicked instead1 question
